Sharon Benzeno, Chief Business Development Officer at Adaptive Biotechnologies Corp (ADPT), sold 13,242 shares at $41.28 ($547K) on 2020-09-01, disclosed to the SEC on 2020-09-02.
Open-market sale of $547k ADPT by Chief Business Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.28 | 6,471 | $267K | 48.9% |
| 2 | $41.28 | 6,471 | $267K | 48.9% |
| 3 | $41.75 | 300 | $13K | 2.3% |
| Total | $41.29 avg | 13,242 | $547K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |